LENZ (LENZ)
Commercializes VIZZ, an FDA-approved aceclidine eye drop for adult presbyopia.
$4.18
After hours+0.05 (+1.26%)
At close$4.13(+1.10%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 111.05% | 34.89M shares | |
|---|---|---|---|
| 152 holders · as of Jun 30, 2026 | |||
| Insiders | 6.35% | 1.99M shares | |
| 6 holders · as of Mar 30, 2026 | |||
| Strategic holders | 5.78% | 1.81M shares | |
| 1 holder · as of Oct 2, 2025 | |||
| Adds to | 123.18% | ||
31.42M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 123.18%; nothing is left for Other.
13F, as of Jun 30, 2026
152 holders · 34.89M shares · 29 new positions · 90 increased · 35 reduced · 27 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 4.18M | 13.30% | 0 | Aug 14, 2026 |
| Alpha Wave Global, LP | 3.61M | 11.50% | 0 | Aug 13, 2026 |
| FMR LLC | 3.56M | 11.33% | −38.9K | Aug 13, 2026 |
| Versant Venture Management, LLC | 2.66M | 8.46% | 0 | Aug 12, 2026 |
| BlackRock, Inc. | 2.29M | 7.30% | +315.3K | Aug 7, 2026 |
| Squarepoint Ops LLC | 1.75M | 5.56% | +240.6K | Aug 14, 2026 |
| Abrdn PLC | 1.55M | 4.93% | +391.7K | Jul 31, 2026 |
| Millennium Management LLC | 1.51M | 4.80% | +639.2K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Rajeev Shahincl. RA Capital Healthcare Fund, L.P., Peter Kolchinsky +1 more | 13.60% | 4.27M | 13D | Nov 7, 2025 |
| BlackRock, Inc. | 5.80% | 1.80M | 13G | Apr 27, 2026 |
| FMR LLC | 5.70% | 1.78M | 13G | Sep 8, 2026 |
| Millennium Management LLC | 5.10% | 1.60M | 13G | Jun 26, 2026 |
| Squarepoint Ops LLC | 5.10% | 1.59M | 13G | Apr 8, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Mar 27, 2026 | Daniel R. Chevallardofficer: Chief Financial Officer | Purchase | 7,500 | $8.57 | 12,886 |
| Mar 27, 2026 | Evert B. Schimmelpenninkdirector, officer: President, CEO and Secretary | Purchase | 28,089 | $8.95 | 77,289 |
| Mar 27, 2026 | Jeffrey P. Georgedirector | Purchase | 5,592 | $8.92 | 5,592 |
| Nov 17, 2025 | Shawn Olssonofficer: Chief Commercial Officer | Sale · 2 lots | 10,000 | $26.10 | 4,733 |
| Nov 7, 2025 | James W. Mccollumdirector | Purchase | 10,500 | $22.79 | 10,500 |
| Nov 7, 2025 | Daniel R. Chevallardofficer: Chief Financial Officer | Purchase · 2 lots | 2,198 | $22.76 | 5,386 |
| Sep 30, 2025 | Versant Venture Capital VI, L.P.10 percent owner | Sale · 6 lots | 224,974 | $46.01 | 1,814,726 |
| Sep 18, 2025 | Versant Venture Capital VI, L.P.10 percent owner | Sale · 6 lots | 135,304 | $42.23 | 2,039,700 |
House and Senate disclosures
Not reported.